Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hypoxia × Magnetic Resonance Spectroscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 130 Breast Neoplasms 92 Lung Neoplasms 67 Brain Neoplasms 62 Carcinoma, Non-Small-Cell Lung 52 Glioblastoma 50 Glioma 46 Pancreatic Neoplasms 34 Neoplasms 33 Neoplasm Metastasis 33 Carcinoma, Hepatocellular 26 Colorectal Neoplasms 25 Carcinoma, Renal Cell 25 Lymphoma, Large B-Cell, Diffuse 24 Multiple Myeloma 23 Melanoma 20 Squamous Cell Carcinoma of Head and Neck 19 Ovarian Neoplasms 19 Lymphoma, Follicular 17 Rectal Neoplasms 16 Head and Neck Neoplasms 16 Astrocytoma 16 Uterine Cervical Neoplasms 15 Urinary Bladder Neoplasms 15 Esophageal Neoplasms 15 Lymphoma 13 Sarcoma 12 Oropharyngeal Neoplasms 12 Lymphoma, B-Cell 12 Leukemia, Lymphocytic, Chronic, B-Cell 12

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 5 pimonidazole 4 fluoroazomycin arabinoside 4 Radiotherapy 3 Injections 3 Propofol 2 gadobutrol 1 fludarabine 1 alovudine 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Temozolomide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Pancreaticoduodenectomy 1 Oxygen 1 Nitroglycerin 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Letrozole 1 Hydroxychloroquine 1 Gemcitabine 1 Furosemide 1 Ferrosoferric Oxide 1 Exercise 1 Dexmedetomidine 1 Cyclophosphamide 1 Circulating Tumor DNA 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02233387 2019-03-08

HX4-cervix

Maastricht Radiation Oncology

Phase 2 Terminated

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡